EUROPEAN UROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2147996, encodeId=6892214e9960e, content=会被秒拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uOxliaENz7T2cgZ2ISAXzRsSIHdTOY55LyrTKQJliargyJYfd9SO4QX5KwnlgFpDSd3PP1BnVTCibgK1LVvOCBMfg/132, createdBy=fe3a2488492, createdName=hj09, createdTime=Fri Jul 14 10:58:33 CST 2023, time=2023-07-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2137959, encodeId=a5b0213e959c9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae56563839, createdName=ms5000001515871327, createdTime=Sat May 20 01:24:53 CST 2023, time=2023-05-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1211304, encodeId=7f5a121130452, content=请问这个杂志收CKD的meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/fe073017e73a415fb92363bbfe4c6652/bc246df7f1fa45cbb92792603c31b81e.jpg, createdBy=ac595326696, createdName=下雨天要打伞, createdTime=Fri Apr 15 00:14:28 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206723, encodeId=81881206e2321, content=投稿命中率:75.0 经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d35403037, createdName=ms6000000942151339, createdTime=Mon Mar 28 21:49:45 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090380, encodeId=b3c61090380e2, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090379, encodeId=d76410903e906, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587752, encodeId=8f9358e752fa, content=师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表: 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , beContent=phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0c52478353, createdName=12451a30m76暂无昵称, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585701, encodeId=d096585e0135, content=不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, beContent=旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75431619080, createdName=heroalt, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581855, encodeId=8faa58185594, content=审稿费和版面费多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GicVmg2CeWYosiaOicqZMU0RPrbxPKvH0ISUyevCfddp6hB8jPBRs4XmnpEecSsM4gLPQ/132, createdBy=a5505246749, createdName=旭旭7430, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577925, encodeId=a1aa5e7925f2, content=有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJz6Gziaazpw0ibZ2NRwl7Rsyt08K2g4IRL1FkcTgQUgtqMY6Z7CFj5t1Wn7bzq9qDRjORpnxNXLia6Q/132, createdBy=7a1a2372163, createdName=大柠檬的土拨鼠, createdTime=Tue Oct 15 00:00:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

2023-07-14 hj09 来自湖北省

会被秒拒吗？

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2147996, encodeId=6892214e9960e, content=会被秒拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uOxliaENz7T2cgZ2ISAXzRsSIHdTOY55LyrTKQJliargyJYfd9SO4QX5KwnlgFpDSd3PP1BnVTCibgK1LVvOCBMfg/132, createdBy=fe3a2488492, createdName=hj09, createdTime=Fri Jul 14 10:58:33 CST 2023, time=2023-07-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2137959, encodeId=a5b0213e959c9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae56563839, createdName=ms5000001515871327, createdTime=Sat May 20 01:24:53 CST 2023, time=2023-05-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1211304, encodeId=7f5a121130452, content=请问这个杂志收CKD的meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/fe073017e73a415fb92363bbfe4c6652/bc246df7f1fa45cbb92792603c31b81e.jpg, createdBy=ac595326696, createdName=下雨天要打伞, createdTime=Fri Apr 15 00:14:28 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206723, encodeId=81881206e2321, content=投稿命中率:75.0 经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d35403037, createdName=ms6000000942151339, createdTime=Mon Mar 28 21:49:45 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090380, encodeId=b3c61090380e2, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090379, encodeId=d76410903e906, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587752, encodeId=8f9358e752fa, content=师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表: 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , beContent=phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0c52478353, createdName=12451a30m76暂无昵称, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585701, encodeId=d096585e0135, content=不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, beContent=旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75431619080, createdName=heroalt, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581855, encodeId=8faa58185594, content=审稿费和版面费多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GicVmg2CeWYosiaOicqZMU0RPrbxPKvH0ISUyevCfddp6hB8jPBRs4XmnpEecSsM4gLPQ/132, createdBy=a5505246749, createdName=旭旭7430, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577925, encodeId=a1aa5e7925f2, content=有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJz6Gziaazpw0ibZ2NRwl7Rsyt08K2g4IRL1FkcTgQUgtqMY6Z7CFj5t1Wn7bzq9qDRjORpnxNXLia6Q/132, createdBy=7a1a2372163, createdName=大柠檬的土拨鼠, createdTime=Tue Oct 15 00:00:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

2023-05-20 ms5000001515871327 来自湖南省

审稿速度:1.0 | 投稿命中率:95.0
经验分享：1

42 0

[GetPortalCommentsPageByObjectIdResponse(id=2147996, encodeId=6892214e9960e, content=会被秒拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uOxliaENz7T2cgZ2ISAXzRsSIHdTOY55LyrTKQJliargyJYfd9SO4QX5KwnlgFpDSd3PP1BnVTCibgK1LVvOCBMfg/132, createdBy=fe3a2488492, createdName=hj09, createdTime=Fri Jul 14 10:58:33 CST 2023, time=2023-07-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2137959, encodeId=a5b0213e959c9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae56563839, createdName=ms5000001515871327, createdTime=Sat May 20 01:24:53 CST 2023, time=2023-05-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1211304, encodeId=7f5a121130452, content=请问这个杂志收CKD的meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/fe073017e73a415fb92363bbfe4c6652/bc246df7f1fa45cbb92792603c31b81e.jpg, createdBy=ac595326696, createdName=下雨天要打伞, createdTime=Fri Apr 15 00:14:28 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206723, encodeId=81881206e2321, content=投稿命中率:75.0 经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d35403037, createdName=ms6000000942151339, createdTime=Mon Mar 28 21:49:45 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090380, encodeId=b3c61090380e2, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090379, encodeId=d76410903e906, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587752, encodeId=8f9358e752fa, content=师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表: 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , beContent=phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0c52478353, createdName=12451a30m76暂无昵称, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585701, encodeId=d096585e0135, content=不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, beContent=旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75431619080, createdName=heroalt, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581855, encodeId=8faa58185594, content=审稿费和版面费多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GicVmg2CeWYosiaOicqZMU0RPrbxPKvH0ISUyevCfddp6hB8jPBRs4XmnpEecSsM4gLPQ/132, createdBy=a5505246749, createdName=旭旭7430, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577925, encodeId=a1aa5e7925f2, content=有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJz6Gziaazpw0ibZ2NRwl7Rsyt08K2g4IRL1FkcTgQUgtqMY6Z7CFj5t1Wn7bzq9qDRjORpnxNXLia6Q/132, createdBy=7a1a2372163, createdName=大柠檬的土拨鼠, createdTime=Tue Oct 15 00:00:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

2022-04-15 下雨天要打伞

请问这个杂志收CKD的meta吗

132 0

[GetPortalCommentsPageByObjectIdResponse(id=2147996, encodeId=6892214e9960e, content=会被秒拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uOxliaENz7T2cgZ2ISAXzRsSIHdTOY55LyrTKQJliargyJYfd9SO4QX5KwnlgFpDSd3PP1BnVTCibgK1LVvOCBMfg/132, createdBy=fe3a2488492, createdName=hj09, createdTime=Fri Jul 14 10:58:33 CST 2023, time=2023-07-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2137959, encodeId=a5b0213e959c9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae56563839, createdName=ms5000001515871327, createdTime=Sat May 20 01:24:53 CST 2023, time=2023-05-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1211304, encodeId=7f5a121130452, content=请问这个杂志收CKD的meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/fe073017e73a415fb92363bbfe4c6652/bc246df7f1fa45cbb92792603c31b81e.jpg, createdBy=ac595326696, createdName=下雨天要打伞, createdTime=Fri Apr 15 00:14:28 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206723, encodeId=81881206e2321, content=投稿命中率:75.0 经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d35403037, createdName=ms6000000942151339, createdTime=Mon Mar 28 21:49:45 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090380, encodeId=b3c61090380e2, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090379, encodeId=d76410903e906, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587752, encodeId=8f9358e752fa, content=师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表: 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , beContent=phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0c52478353, createdName=12451a30m76暂无昵称, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585701, encodeId=d096585e0135, content=不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, beContent=旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75431619080, createdName=heroalt, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581855, encodeId=8faa58185594, content=审稿费和版面费多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GicVmg2CeWYosiaOicqZMU0RPrbxPKvH0ISUyevCfddp6hB8jPBRs4XmnpEecSsM4gLPQ/132, createdBy=a5505246749, createdName=旭旭7430, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577925, encodeId=a1aa5e7925f2, content=有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJz6Gziaazpw0ibZ2NRwl7Rsyt08K2g4IRL1FkcTgQUgtqMY6Z7CFj5t1Wn7bzq9qDRjORpnxNXLia6Q/132, createdBy=7a1a2372163, createdName=大柠檬的土拨鼠, createdTime=Tue Oct 15 00:00:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

2022-03-28 ms6000000942151339

投稿命中率:75.0
经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。

138 0

[GetPortalCommentsPageByObjectIdResponse(id=2147996, encodeId=6892214e9960e, content=会被秒拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uOxliaENz7T2cgZ2ISAXzRsSIHdTOY55LyrTKQJliargyJYfd9SO4QX5KwnlgFpDSd3PP1BnVTCibgK1LVvOCBMfg/132, createdBy=fe3a2488492, createdName=hj09, createdTime=Fri Jul 14 10:58:33 CST 2023, time=2023-07-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2137959, encodeId=a5b0213e959c9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae56563839, createdName=ms5000001515871327, createdTime=Sat May 20 01:24:53 CST 2023, time=2023-05-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1211304, encodeId=7f5a121130452, content=请问这个杂志收CKD的meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/fe073017e73a415fb92363bbfe4c6652/bc246df7f1fa45cbb92792603c31b81e.jpg, createdBy=ac595326696, createdName=下雨天要打伞, createdTime=Fri Apr 15 00:14:28 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206723, encodeId=81881206e2321, content=投稿命中率:75.0 经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d35403037, createdName=ms6000000942151339, createdTime=Mon Mar 28 21:49:45 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090380, encodeId=b3c61090380e2, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090379, encodeId=d76410903e906, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587752, encodeId=8f9358e752fa, content=师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表: 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , beContent=phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0c52478353, createdName=12451a30m76暂无昵称, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585701, encodeId=d096585e0135, content=不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, beContent=旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75431619080, createdName=heroalt, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581855, encodeId=8faa58185594, content=审稿费和版面费多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GicVmg2CeWYosiaOicqZMU0RPrbxPKvH0ISUyevCfddp6hB8jPBRs4XmnpEecSsM4gLPQ/132, createdBy=a5505246749, createdName=旭旭7430, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577925, encodeId=a1aa5e7925f2, content=有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJz6Gziaazpw0ibZ2NRwl7Rsyt08K2g4IRL1FkcTgQUgtqMY6Z7CFj5t1Wn7bzq9qDRjORpnxNXLia6Q/132, createdBy=7a1a2372163, createdName=大柠檬的土拨鼠, createdTime=Tue Oct 15 00:00:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

结果中的重要文献是在结果体现，还是在引言中描述？

145 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147996, encodeId=6892214e9960e, content=会被秒拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uOxliaENz7T2cgZ2ISAXzRsSIHdTOY55LyrTKQJliargyJYfd9SO4QX5KwnlgFpDSd3PP1BnVTCibgK1LVvOCBMfg/132, createdBy=fe3a2488492, createdName=hj09, createdTime=Fri Jul 14 10:58:33 CST 2023, time=2023-07-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2137959, encodeId=a5b0213e959c9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae56563839, createdName=ms5000001515871327, createdTime=Sat May 20 01:24:53 CST 2023, time=2023-05-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1211304, encodeId=7f5a121130452, content=请问这个杂志收CKD的meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/fe073017e73a415fb92363bbfe4c6652/bc246df7f1fa45cbb92792603c31b81e.jpg, createdBy=ac595326696, createdName=下雨天要打伞, createdTime=Fri Apr 15 00:14:28 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206723, encodeId=81881206e2321, content=投稿命中率:75.0 经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d35403037, createdName=ms6000000942151339, createdTime=Mon Mar 28 21:49:45 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090380, encodeId=b3c61090380e2, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090379, encodeId=d76410903e906, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587752, encodeId=8f9358e752fa, content=师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表: 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , beContent=phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0c52478353, createdName=12451a30m76暂无昵称, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585701, encodeId=d096585e0135, content=不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, beContent=旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75431619080, createdName=heroalt, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581855, encodeId=8faa58185594, content=审稿费和版面费多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GicVmg2CeWYosiaOicqZMU0RPrbxPKvH0ISUyevCfddp6hB8jPBRs4XmnpEecSsM4gLPQ/132, createdBy=a5505246749, createdName=旭旭7430, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577925, encodeId=a1aa5e7925f2, content=有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJz6Gziaazpw0ibZ2NRwl7Rsyt08K2g4IRL1FkcTgQUgtqMY6Z7CFj5t1Wn7bzq9qDRjORpnxNXLia6Q/132, createdBy=7a1a2372163, createdName=大柠檬的土拨鼠, createdTime=Tue Oct 15 00:00:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

2021-12-27 Gym璨烨

引言三段式指的是什么?

145 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147996, encodeId=6892214e9960e, content=会被秒拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uOxliaENz7T2cgZ2ISAXzRsSIHdTOY55LyrTKQJliargyJYfd9SO4QX5KwnlgFpDSd3PP1BnVTCibgK1LVvOCBMfg/132, createdBy=fe3a2488492, createdName=hj09, createdTime=Fri Jul 14 10:58:33 CST 2023, time=2023-07-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2137959, encodeId=a5b0213e959c9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae56563839, createdName=ms5000001515871327, createdTime=Sat May 20 01:24:53 CST 2023, time=2023-05-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1211304, encodeId=7f5a121130452, content=请问这个杂志收CKD的meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/fe073017e73a415fb92363bbfe4c6652/bc246df7f1fa45cbb92792603c31b81e.jpg, createdBy=ac595326696, createdName=下雨天要打伞, createdTime=Fri Apr 15 00:14:28 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206723, encodeId=81881206e2321, content=投稿命中率:75.0 经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d35403037, createdName=ms6000000942151339, createdTime=Mon Mar 28 21:49:45 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090380, encodeId=b3c61090380e2, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090379, encodeId=d76410903e906, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587752, encodeId=8f9358e752fa, content=师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表: 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , beContent=phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0c52478353, createdName=12451a30m76暂无昵称, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585701, encodeId=d096585e0135, content=不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, beContent=旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75431619080, createdName=heroalt, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581855, encodeId=8faa58185594, content=审稿费和版面费多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GicVmg2CeWYosiaOicqZMU0RPrbxPKvH0ISUyevCfddp6hB8jPBRs4XmnpEecSsM4gLPQ/132, createdBy=a5505246749, createdName=旭旭7430, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577925, encodeId=a1aa5e7925f2, content=有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJz6Gziaazpw0ibZ2NRwl7Rsyt08K2g4IRL1FkcTgQUgtqMY6Z7CFj5t1Wn7bzq9qDRjORpnxNXLia6Q/132, createdBy=7a1a2372163, createdName=大柠檬的土拨鼠, createdTime=Tue Oct 15 00:00:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

2020-03-30 12451a30m76暂无昵称

师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表::
研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表:
2017-11-10 Submit
2017-11-26 Revision needed
2017-12-25 Submit Revision
2018-01-09 Revision needed
2018-02-05 Submit Revision
2018-02-13 Accept

phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept

276 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147996, encodeId=6892214e9960e, content=会被秒拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uOxliaENz7T2cgZ2ISAXzRsSIHdTOY55LyrTKQJliargyJYfd9SO4QX5KwnlgFpDSd3PP1BnVTCibgK1LVvOCBMfg/132, createdBy=fe3a2488492, createdName=hj09, createdTime=Fri Jul 14 10:58:33 CST 2023, time=2023-07-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2137959, encodeId=a5b0213e959c9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae56563839, createdName=ms5000001515871327, createdTime=Sat May 20 01:24:53 CST 2023, time=2023-05-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1211304, encodeId=7f5a121130452, content=请问这个杂志收CKD的meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/fe073017e73a415fb92363bbfe4c6652/bc246df7f1fa45cbb92792603c31b81e.jpg, createdBy=ac595326696, createdName=下雨天要打伞, createdTime=Fri Apr 15 00:14:28 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206723, encodeId=81881206e2321, content=投稿命中率:75.0 经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d35403037, createdName=ms6000000942151339, createdTime=Mon Mar 28 21:49:45 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090380, encodeId=b3c61090380e2, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090379, encodeId=d76410903e906, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587752, encodeId=8f9358e752fa, content=师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表: 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , beContent=phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0c52478353, createdName=12451a30m76暂无昵称, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585701, encodeId=d096585e0135, content=不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, beContent=旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75431619080, createdName=heroalt, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581855, encodeId=8faa58185594, content=审稿费和版面费多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GicVmg2CeWYosiaOicqZMU0RPrbxPKvH0ISUyevCfddp6hB8jPBRs4XmnpEecSsM4gLPQ/132, createdBy=a5505246749, createdName=旭旭7430, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577925, encodeId=a1aa5e7925f2, content=有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJz6Gziaazpw0ibZ2NRwl7Rsyt08K2g4IRL1FkcTgQUgtqMY6Z7CFj5t1Wn7bzq9qDRjORpnxNXLia6Q/132, createdBy=7a1a2372163, createdName=大柠檬的土拨鼠, createdTime=Tue Oct 15 00:00:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

2020-03-02 heroalt

不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表:
审稿费和版面费多少钱

旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱

277 0

[GetPortalCommentsPageByObjectIdResponse(id=2147996, encodeId=6892214e9960e, content=会被秒拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uOxliaENz7T2cgZ2ISAXzRsSIHdTOY55LyrTKQJliargyJYfd9SO4QX5KwnlgFpDSd3PP1BnVTCibgK1LVvOCBMfg/132, createdBy=fe3a2488492, createdName=hj09, createdTime=Fri Jul 14 10:58:33 CST 2023, time=2023-07-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2137959, encodeId=a5b0213e959c9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae56563839, createdName=ms5000001515871327, createdTime=Sat May 20 01:24:53 CST 2023, time=2023-05-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1211304, encodeId=7f5a121130452, content=请问这个杂志收CKD的meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/fe073017e73a415fb92363bbfe4c6652/bc246df7f1fa45cbb92792603c31b81e.jpg, createdBy=ac595326696, createdName=下雨天要打伞, createdTime=Fri Apr 15 00:14:28 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206723, encodeId=81881206e2321, content=投稿命中率:75.0 经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d35403037, createdName=ms6000000942151339, createdTime=Mon Mar 28 21:49:45 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090380, encodeId=b3c61090380e2, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090379, encodeId=d76410903e906, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587752, encodeId=8f9358e752fa, content=师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表: 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , beContent=phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0c52478353, createdName=12451a30m76暂无昵称, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585701, encodeId=d096585e0135, content=不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, beContent=旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75431619080, createdName=heroalt, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581855, encodeId=8faa58185594, content=审稿费和版面费多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GicVmg2CeWYosiaOicqZMU0RPrbxPKvH0ISUyevCfddp6hB8jPBRs4XmnpEecSsM4gLPQ/132, createdBy=a5505246749, createdName=旭旭7430, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577925, encodeId=a1aa5e7925f2, content=有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJz6Gziaazpw0ibZ2NRwl7Rsyt08K2g4IRL1FkcTgQUgtqMY6Z7CFj5t1Wn7bzq9qDRjORpnxNXLia6Q/132, createdBy=7a1a2372163, createdName=大柠檬的土拨鼠, createdTime=Tue Oct 15 00:00:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

2019-12-20 旭旭7430

审稿费和版面费多少钱

295 0

[GetPortalCommentsPageByObjectIdResponse(id=2147996, encodeId=6892214e9960e, content=会被秒拒吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uOxliaENz7T2cgZ2ISAXzRsSIHdTOY55LyrTKQJliargyJYfd9SO4QX5KwnlgFpDSd3PP1BnVTCibgK1LVvOCBMfg/132, createdBy=fe3a2488492, createdName=hj09, createdTime=Fri Jul 14 10:58:33 CST 2023, time=2023-07-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2137959, encodeId=a5b0213e959c9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae56563839, createdName=ms5000001515871327, createdTime=Sat May 20 01:24:53 CST 2023, time=2023-05-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1211304, encodeId=7f5a121130452, content=请问这个杂志收CKD的meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/fe073017e73a415fb92363bbfe4c6652/bc246df7f1fa45cbb92792603c31b81e.jpg, createdBy=ac595326696, createdName=下雨天要打伞, createdTime=Fri Apr 15 00:14:28 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206723, encodeId=81881206e2321, content=投稿命中率:75.0 经验分享：请问投稿指南中的 statistical code指的是什么？不太理解这个指得到底是什么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d35403037, createdName=ms6000000942151339, createdTime=Mon Mar 28 21:49:45 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090380, encodeId=b3c61090380e2, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090379, encodeId=d76410903e906, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587752, encodeId=8f9358e752fa, content=师兄你好，想请问您发的eu是原始研究吗？想加您一个微信我是研二的泌尿外学生phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept phosphoakt 2018-03-02 09:10:00 发表: 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , beContent=phosphoakt 2018-03-02 发表:: 研究方向：Prostate cancer;CRPC; 接收率：约50% 审稿时间：约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0c52478353, createdName=12451a30m76暂无昵称, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585701, encodeId=d096585e0135, content=不需要审稿费和版面费旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, beContent=旭旭 2019-12-20 00:00:00 发表: 审稿费和版面费多少钱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75431619080, createdName=heroalt, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581855, encodeId=8faa58185594, content=审稿费和版面费多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GicVmg2CeWYosiaOicqZMU0RPrbxPKvH0ISUyevCfddp6hB8jPBRs4XmnpEecSsM4gLPQ/132, createdBy=a5505246749, createdName=旭旭7430, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577925, encodeId=a1aa5e7925f2, content=有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJz6Gziaazpw0ibZ2NRwl7Rsyt08K2g4IRL1FkcTgQUgtqMY6Z7CFj5t1Wn7bzq9qDRjORpnxNXLia6Q/132, createdBy=7a1a2372163, createdName=大柠檬的土拨鼠, createdTime=Tue Oct 15 00:00:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

2019-10-15 大柠檬的土拨鼠

有收，极少156****3225暂无昵称 2019-06-21 00:00:00 发表:
这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究

156****3225暂无昵称 2019-06-21 00:00:00 发表: 这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究

313 0

内科

外科

专科科室

热点

按科室浏览

科研工具

写作工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务